<bill session="119" type="h" number="6868" updated="2026-01-22T15:13:48Z">
  <state datetime="2025-12-18">REFERRED</state>
  <status>
    <introduced datetime="2025-12-18"/>
  </status>
  <introduced datetime="2025-12-18"/>
  <titles>
    <title type="display">ACCESS Through OTC Innovation Act</title>
    <title type="short" as="introduced">ACCESS Through OTC Innovation Act</title>
    <title type="short" as="introduced">Advancing Consumer Choice, Equity, Safety, and Self-Care Through OTC Innovation Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="L000601"/>
  <cosponsors/>
  <actions>
    <action datetime="2025-12-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-12-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
</bill>
